A National Survey of the Infectious Diseases Society of America Emerging Infections Network concerning Neuraminidase Inhibitor Prescription Practices and Pandemic Influenza Preparations | Zendy

Justin R. Ortiz | Zendy; David K. Shay | Zendy; Laura A. Liedtke | Zendy; Joseph S. Bresee | Zendy; L. J. Strausbaugh | Zendy

Open Access

A National Survey of the Infectious Diseases Society of America Emerging Infections Network concerning Neuraminidase Inhibitor Prescription Practices and Pandemic Influenza Preparations

Author(s) -

Justin R. Ortiz,

David K. Shay,

Laura A. Liedtke,

Joseph S. Bresee,

L. J. Strausbaugh

Publication year - 2006

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/505975

Subject(s) - medicine , neuraminidase , pandemic , medical prescription , neuraminidase inhibitor , government (linguistics) , family medicine , covid-19 , environmental health , intensive care medicine , virology , infectious disease (medical specialty) , virus , pharmacology , disease , linguistics , philosophy

This report summarizes the findings of a national survey of infectious diseases consultants regarding their use of neuraminidase inhibitors and the status of their planning for an influenza pandemic. The respondents indicated that government stockpiles should be increased, that many have received requests for antiviral medications, and that additional recommendations regarding the appropriate use of antiviral medications would be helpful.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research